Molecular immune mechanisms of HPV‐infected HaCaT cells in vitro based on toll‐like receptors signaling pathway

摘要

Objective To explore the molecular immune mechanism of HPV‐infected HaCaT cells in vitro based on TLRs signaling pathway by analyzing the effects of interfering TLRs on inflammatory and immune factors in the signaling pathway. Methods FCM was used to analyze the proportion of Th1, Th2, Th17, and Treg cells in blood samples. HPV‐infected HaCaT cells were divided into five groups: A, B, C, D, and E. Group A added TLR3 antagonist, group B added TLR9 antagonist, group C added equivalent saline, group D added IRF3 agonist, and group E added IRF3 inhibitor. Immunohistochemistry was used to analyze the expression of TLR3 and TLR9 in HaCaT cell model; ELISA was used to analyze the expression of inflammatory factors IL‐2, TNF‐a, and IFN‐beta; WB was used to analyze the expression of TRAF3, IKK epsilon, and TBK1; RT‐PCR was used to analyze the expression of IRF3 and IRF7 in each cell model. Results The proportion of blood immune cells in patients with HPV infection was Th1, Th17, Th2, and Treg, with statistical significance ( P ?.05); the expression of IL‐2, TNF‐alpha, IFN‐beta in each group, TLR3, and TLR9 was higher than that in negative control group ( P ?.05). The expression of TRAF3, IKK epsilon, and TBK1 in the control group was higher than that in the TLR3 and TLR9 inhibitor groups, and the expression of IRF3 and IRF7 in the TLR9 inhibitor group was higher than that in the TLR3 inhibitor group ( P ?.05); the expression of IRF3 and IRF7 in the TLR3i and TLR9i inhibitor groups was lower than that in the TLR3 inhibitor group ( P ?.05). Compared with?the control group, IRF3a group was higher than the control group, IRF3i group was lower than the control group, the difference was statistically significant ( P ?.05). Conclusion TLR3 and TLR9, the key factors of TLRs, are highly expressed in HaCaT cells infected with HPV. Through TLRs‐IKK‐e‐IRFs‐IFN signaling pathway, they can induce high expression of inflammatory factors, IKK‐e, IRFs, and IFN, and improve immunity.